CAR-T Meeting 2026 | The evolving role of nurses in the rapidly expanding field of CAR T-cell therapy
In this video, Erik Aerts, RN, University of Zurich, Zurich, Switzerland, briefly discusses the evolving role of nurses in the expanding field of cellular therapies, highlighting the importance of education to equip nurses to address the challenges posed by increasing patient numbers and expanding indications. This interview took place at the EBMT-EHA 8th European CAR T-cell Meeting, held in Palma de Mallorca, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
That’s a very, very good question and an important question, because we do not only see that the numbers are going up from CAR T-cell therapies, but also the indications will expand. And that will be a huge challenge in the upcoming years for nurses and other healthcare professionals, talking about CAR T-cell in dermatology, in rheumatology, in neurology. For example, CAR T-cell, there was a good talk yesterday from CAR T-cell therapy for patients with multiple sclerosis...
That’s a very, very good question and an important question, because we do not only see that the numbers are going up from CAR T-cell therapies, but also the indications will expand. And that will be a huge challenge in the upcoming years for nurses and other healthcare professionals, talking about CAR T-cell in dermatology, in rheumatology, in neurology. For example, CAR T-cell, there was a good talk yesterday from CAR T-cell therapy for patients with multiple sclerosis. So there are other groups of patients and that will be a huge challenge for nurses to deal with those patients. So again, also their education is the cornerstone.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
